Data / Drug companies / Teva Api India Private Ltd
Teva Api India Private Ltd: 36 products in the FDA NDC directory, labeler code 15894
Teva Api India Private Ltd (labeler code 15894) lists 36 products in the FDA National Drug Code Directory. By type: 36 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 11, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 15894
- Products in commercial distribution
- 36
- Packages
- 36
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1, Schedule V 1
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- August 9, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 97.2% |
| Bulk ingredients for compounding | 1 | 2.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 36 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 35 | 97.2% |
| Poultice | 1 | 2.8% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ferric carboxy maltose | 15894-0048 | Powder | Bulk ingredients | May 11, 2026 |
| Ferric derisomaltose | 15894-0047 | Powder | Bulk ingredients | May 4, 2026 |
| Resmetirom | 15894-0045 | Powder | Bulk ingredients | February 10, 2026 |
| Teva api india | 15894-0044 | Powder | Bulk ingredients | November 20, 2025 |
| Zolpidem tartrate | 15894-0043 | Powder | Bulk ingredients | January 14, 2025 |
| Sodium caprate | 15894-0042 | Powder | Bulk ingredients | December 3, 2024 |
| Fluoxetine hcl | 15894-0039 | Powder | Bulk ingredients | April 3, 2024 |
| Triheptanoin | 15894-0041 | Powder | Bulk ingredients | January 3, 2024 |
| Pioglitazone hydrochloride | 15894-0017 | Powder | Bulk ingredients | March 15, 2023 |
| Carbidopa | 15894-0040 | Powder | Bulk ingredients | February 23, 2023 |
| Methyldopa | 15894-0038 | Powder | Bulk ingredients | January 24, 2022 |
| Glycerol phenyl butyrate | 15894-0037 | Powder | Bulk ingredients | January 27, 2021 |
| Docosanol | 15894-0036 | Powder | Bulk ingredients | October 13, 2020 |
| Doxepin hcl | 15894-0035 | Powder | Bulk ingredients | April 30, 2020 |
| Imipramine hydrochloride | 15894-0034 | Powder | Bulk ingredients | August 19, 2019 |
| Irbesartan | 15894-0008 | Powder | Bulk ingredients | August 19, 2019 |
| Montelukast sodium | 15894-0004 | Powder | Bulk ingredients | August 19, 2019 |
| Olanzapine | 15894-0006 | Powder | Bulk ingredients | July 15, 2019 |
| Pregabalin | 15894-0016 | Powder | Bulk ingredients | March 26, 2019 |
| Amitriptyline hydrochloride | 15894-0033 | Powder | Bulk ingredients | January 23, 2019 |
| Caspofungin acetate ih | 15894-0014 | Powder | Bulk ingredients | November 17, 2017 |
| Ezetimibe | 15894-0011 | Powder | Bulk ingredients | November 17, 2017 |
| Rilpivirine hcl | 15894-0032 | Powder | Bulk ingredients | August 1, 2016 |
| Eletriptan hydrobromide ih | 15894-0031 | Powder | Bulk ingredients | May 26, 2016 |
| Ticagrelor | 15894-0030 | Powder | Bulk ingredients | December 14, 2015 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.